The current PE ratio of NEOG cannot be calculated, as the latest EPS of -$0.11 is negative. The last PE ratio of Neogen, recorded in February 2024, was 859.5.
The PE ratio of Neogen has averaged 107.38 over the last ten years. Analyzing the last ten years, NEOG's PE ratio reached its highest point in the Feb 2024 quarter at 859.5, when the price was $17.19 and the EPS was $0.02. The lowest point was recorded in the May 2019 quarter, when it reached 48.58 with a price of $28.18 and an EPS of $0.58.
Maximum annual increase: 29.61% in 2021
Maximum annual decrease: -27.38% in 2022
Year | PE ratio | Change |
---|---|---|
2024 | N/A | N/A |
2023 | N/A | N/A |
2022 | 58.8 | -27.38% |
2021 | 80.97 | 29.61% |
2020 | 62.47 | 28.59% |
2019 | 48.58 | -20.44% |
2018 | 61.06 | 13.2% |
2017 | 53.94 | 7.79% |
2016 | 50.04 | -2.93% |
2015 | 51.55 | 5.48% |
Stock name | PE ratio | Market cap |
---|---|---|
TMO Thermo Fisher Scientific Inc | 32.77 | $200.45B |
BDX Becton Dickinson & Co | 38.72 | $65.83B |
IDXX Idexx Laboratories Inc | 39.38 | $33.76B |
DHR Danaher Corp | 43.2 | $165.08B |
ILMN Illumina Inc | N/A | $21.57B |
PACB Pacific Biosciences Of California Inc | N/A | $539.51M |
NEOG Neogen Corp | N/A | $2.61B |
The current price to earnings ratio of NEOG cannot be determined, as its EPS of -$0.11 is negative.
As an average over the last 3 years, NEOG stock has a PE ratio of 296.18.
As an average over the last 5 years, NEOG stock has a PE ratio of 174.57.
Over the last ten years, the quarterly PE ratio reached its highest level at 859.5 in the Feb 2024 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.